🇺🇸 FDA
Patent

US 7176179

Selective induction of cell death by delivery of amino-terminal interleukin-1-α pro-piece polypeptide

granted A61KA61K38/00A61K48/00

Quick answer

US patent 7176179 (Selective induction of cell death by delivery of amino-terminal interleukin-1-α pro-piece polypeptide) held by The Regents of the University of California expires Mon Feb 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 13 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K38/00, A61K48/00